<?xml version="1.0" encoding="UTF-8"?>
<p>We passed homogenized mosquito or serum samples through 0.45-μm filters (Corning Inc., 
 <ext-link ext-link-type="uri" xlink:href="https://www.corning.com" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.corning.com</ext-link>) and inoculated filtrates onto monolayers of 3 culture cell lines (mammalian cell lines Vero9013 and BHK-21 and mosquito cell line C6/36). We assessed cytopathic effect (CPE) daily and collected supernatants from cells that exhibited CPE. If we observed no CPE, we passaged the cells 5 times for 7 days each, after which, if virus was present, CPE should have become apparent. We extracted RNA from culture supernatants using the QIAamp Viral RNA Mini Kit (QIAGEN, 
 <ext-link ext-link-type="uri" xlink:href="https://www.qiagen.com" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.qiagen.com</ext-link>) and subjected the resulting RNA to reverse transcription PCR (RT-PCR) using the QIAGEN One-Step RT-PCR Kit and 2 universal flavivirus-specific primer sets (MAMD and cFD2 or FU2 and cFD3) (
 <xref rid="R8" ref-type="bibr">
  <italic>8</italic>
 </xref>,
 <xref rid="R9" ref-type="bibr">
  <italic>9</italic>
 </xref>) to screen for flaviviruses. To determine genome sequences, we used the QIAGEN One-Step RT-PCR Kit, TaKaRa LA RT-PCR Kit version 2.1 (Takara Bio, 
 <ext-link ext-link-type="uri" xlink:href="https://www.takarabio.com" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.takarabio.com</ext-link>), and Invitrogen 5′ RACE System for Rapid Amplification of cDNA Ends version 2.0 (
 <ext-link ext-link-type="uri" xlink:href="https://www.thermofisher.com" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.thermofisher.com</ext-link>) as needed in combination with several JEV-specific primers (
 <xref ref-type="local-data" rid="SD1">Appendix</xref> Table 1).
</p>
